SMT201400037B - Nuovi agenti antibatterici per il trattamento di infezioni grampositive - Google Patents

Nuovi agenti antibatterici per il trattamento di infezioni grampositive

Info

Publication number
SMT201400037B
SMT201400037B SM201400037T SM201400037T SMT201400037B SM T201400037 B SMT201400037 B SM T201400037B SM 201400037 T SM201400037 T SM 201400037T SM 201400037 T SM201400037 T SM 201400037T SM T201400037 B SMT201400037 B SM T201400037B
Authority
SM
San Marino
Prior art keywords
gram
treatment
antibacterial agents
new antibacterial
positive infections
Prior art date
Application number
SM201400037T
Other languages
English (en)
Italian (it)
Inventor
Andre Lee Pearson
Chester A Metcalf Iii
Jing Li
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of SMT201400037B publication Critical patent/SMT201400037B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SM201400037T 2008-12-22 2014-03-28 Nuovi agenti antibatterici per il trattamento di infezioni grampositive SMT201400037B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
SMT201400037B true SMT201400037B (it) 2014-05-07

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400037T SMT201400037B (it) 2008-12-22 2014-03-28 Nuovi agenti antibatterici per il trattamento di infezioni grampositive

Country Status (26)

Country Link
US (3) US8507647B2 (enExample)
EP (2) EP2674437A1 (enExample)
JP (1) JP5670914B2 (enExample)
KR (1) KR101717795B1 (enExample)
CN (1) CN102325787B (enExample)
AR (1) AR074833A1 (enExample)
AU (1) AU2009330245C1 (enExample)
BR (1) BRPI0923567A2 (enExample)
CA (1) CA2747965C (enExample)
CY (1) CY1114883T1 (enExample)
DK (1) DK2379580T3 (enExample)
ES (1) ES2442167T3 (enExample)
HR (1) HRP20131170T1 (enExample)
IL (1) IL213638A0 (enExample)
MX (1) MX2011006803A (enExample)
NZ (1) NZ594019A (enExample)
PL (1) PL2379580T3 (enExample)
PT (1) PT2379580E (enExample)
RS (1) RS53152B (enExample)
RU (1) RU2512396C2 (enExample)
SG (1) SG172299A1 (enExample)
SI (1) SI2379580T1 (enExample)
SM (1) SMT201400037B (enExample)
TW (1) TWI444198B (enExample)
WO (1) WO2010075215A1 (enExample)
ZA (1) ZA201104693B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2013157188A (ru) 2011-05-26 2015-07-10 Кьюбист Фармасьютикалз, Инк. Композиции св-183,315 и относящиеся к ним способы
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
MX386103B (es) * 2016-04-22 2025-03-18 Astrazeneca Ab Inhibidores de mcl-1 y metodos de uso de los mismos.
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) * 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
US4812470A (en) 1982-02-27 1989-03-14 Beecham Group P.L.C. Antibacterial monic acid derivatives
US4399067A (en) 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4482487A (en) 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CS276978B6 (en) 1984-10-09 1992-11-18 Lilly Co Eli Process for preparing a-21978c antibiotic derivative
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039660A (en) 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
CA2043762C (en) 1990-06-07 2001-05-29 Adam J. Kreuzman Lipopeptide deacylase
AU7497594A (en) 1993-08-13 1995-03-14 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
CA2248348C (en) 1996-03-08 2008-06-10 Fujisawa Pharmaceutical Co., Ltd. Process for the deacylation of cyclic lipopeptides
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
HK1040363B (en) 1998-09-25 2007-01-26 Cubist Pharmaceuticals Llc Use of daptomycin
JP2003520353A (ja) 1999-11-03 2003-07-02 ザ ウィタカー コーポレーション マルチファイバアレー用光電子モジュール
WO2001044271A2 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
KR20020063228A (ko) 1999-12-15 2002-08-01 큐비스트 파마슈티컬즈 인코포레이티드 항균제로서 리포펩티드
US6911525B2 (en) * 1999-12-15 2005-06-28 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
EP1423137B1 (en) 2001-08-06 2009-04-29 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
EP1814588A2 (en) * 2004-11-12 2007-08-08 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides

Also Published As

Publication number Publication date
KR101717795B1 (ko) 2017-03-17
PT2379580E (pt) 2014-01-20
AU2009330245C1 (en) 2013-09-26
HRP20131170T1 (hr) 2014-01-03
JP2012513467A (ja) 2012-06-14
HK1161886A1 (en) 2012-08-10
EP2379580A1 (en) 2011-10-26
AR074833A1 (es) 2011-02-16
TW201028161A (en) 2010-08-01
EP2674437A1 (en) 2013-12-18
ZA201104693B (en) 2013-01-30
AU2009330245A1 (en) 2011-08-04
JP5670914B2 (ja) 2015-02-18
AU2009330245B2 (en) 2013-05-02
ES2442167T3 (es) 2014-02-10
NZ594019A (en) 2013-08-30
DK2379580T3 (da) 2014-01-20
SG172299A1 (en) 2011-07-28
WO2010075215A1 (en) 2010-07-01
CY1114883T1 (el) 2016-12-14
CN102325787A (zh) 2012-01-18
KR20110114592A (ko) 2011-10-19
PL2379580T3 (pl) 2014-05-30
CA2747965A1 (en) 2010-07-01
SI2379580T1 (sl) 2014-02-28
CN102325787B (zh) 2014-05-28
US20100184649A1 (en) 2010-07-22
CA2747965C (en) 2017-06-27
EP2379580B1 (en) 2013-10-23
RU2011130278A (ru) 2013-01-27
MX2011006803A (es) 2011-09-06
US20150337013A1 (en) 2015-11-26
US20140073558A1 (en) 2014-03-13
TWI444198B (zh) 2014-07-11
BRPI0923567A2 (pt) 2016-09-27
US8507647B2 (en) 2013-08-13
RS53152B (sr) 2014-06-30
RU2512396C2 (ru) 2014-04-10
IL213638A0 (en) 2011-07-31

Similar Documents

Publication Publication Date Title
SMT201400037B (it) Nuovi agenti antibatterici per il trattamento di infezioni grampositive
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
SMT201500117B (it) Composti antibatterici
ES2898695T8 (es) Derivados de benzoxaborol para el tratamiento de infecciones bacterianas
ATE507225T1 (de) Antibakterielle polycyclische harnstoffverbindungen
IL205254A0 (en) Process for the preparation of macrolide antibacterial agents
BR112012002628A2 (pt) "composição para tratamento de infecções por hbv"
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
PL2205720T3 (pl) Kompozycja do leczenia stwardnienia rozsianego
EP2460405A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCE
EP3150631C0 (en) PASSIVE ANTI-GLUCOSAMINIDASE IMMUNIZATION FOR STAPHYLOCOCCUS AUREUS INFECTIONS
SMT201500086B (it) Uso del nifuratel per il trattamento di infezioni causate dalla specie atopobium
EP2473482A4 (en) METHOD FOR TREATING ORTHOMYXOVIRUS INFECTIONS
EP2236143A4 (en) ANTIMICROBIOTICS FOR GRAM-POSITIVE BACTERIA
BRPI0914139A2 (pt) composições pediátricas para o tratamento de esclerose múltipla
EP1881760A4 (en) ANTIMICROBIAL THERAPY OF BACTERIAL INFECTIONS
BR112012004643A2 (pt) compostos antibióticos
BR112012004587A2 (pt) composto antibacteriano de hidroxifenila
BR112012002267A2 (pt) compostos para o tratamento de inflamação.
BRPI0922216A2 (pt) tratamento para glomerulonefrite
IT1392206B1 (it) Apparato per la produzione di spazzole o scope
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
ZA201100468B (en) The treatment of helminthic infections
DK2321306T3 (da) 3-Cyanopyrrolidinyl-phenyl-oxazolidinoner som antibakterielle midler